The beneficial effects of protein tyrosine kinase inhibition on the circulatory failure induced by endotoxin in the rat

Implication of enhanced activity of tyrosine kinases has been established in the pathophysiology of many diseases associated with local (e.g., atherosclerosis) or systemic (e.g., septic shock) inflammation. The main objective of this study was to elucidate whether tyrosine kinase and nitric oxide we...

Full description

Saved in:

Bibliographic Details
Published in:	Shock (Augusta, Ga.) Vol. 18; no. 5; pp. 450 - 455
Main Authors:	FATEHI, Mohammad, ANVARI, Khaleda, FATEHI-HASSANABAD, Zahra
Format:	Journal Article
Language:	English
Published:	Augusta, GA BioMedical Press 01-11-2002
Subjects:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Biological and medical sciences Drug Interactions Emergency and intensive care: infection, septic shock Endotoxins - toxicity Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - pharmacology Genistein - administration & dosage Genistein - pharmacology Hemodynamics - drug effects In Vitro Techniques Intensive care medicine Male Medical sciences NG-Nitroarginine Methyl Ester - administration & dosage NG-Nitroarginine Methyl Ester - pharmacology Phenylephrine - administration & dosage Phenylephrine - pharmacology Protein-Tyrosine Kinases - antagonists & inhibitors Rats Rats, Sprague-Dawley Shock, Septic - drug therapy Shock, Septic - enzymology Shock, Septic - physiopathology Splanchnic Circulation - drug effects Splanchnic Circulation - physiology Sympathetic Nervous System - drug effects Sympathetic Nervous System - physiopathology Vasoconstriction - drug effects Vasoconstriction - physiology Shock Animal model Pathophysiology Rat Enzyme Transferases Genistein Rodentia Cardiovascular disease Endotoxin Isoflavone derivatives Infection Sepsis syndrome Toxin Ester Vertebrata Mammalia Arginine Aminoacid Animal Phenylephrine Protein-tyrosine kinase
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Implication of enhanced activity of tyrosine kinases has been established in the pathophysiology of many diseases associated with local (e.g., atherosclerosis) or systemic (e.g., septic shock) inflammation. The main objective of this study was to elucidate whether tyrosine kinase and nitric oxide were involved in endotoxin-induced impairment of vascular responses to sympathetic nerve stimulation (SNS) in rat isolated mesenteric bed. Therefore, the effects of genistein, an inhibitor of protein tyrosine kinase, and L-NAME (N-nitro-L-arginine methyl ester), an inhibitor of nitric oxide synthase, on endotoxin-induced shock were investigated in the thiopental-anesthetized rats. We also studied the effects of endotoxin on the vasoconstrictor responses to SNS in the rat isolated perfused mesenteric bed. Endotoxin injection (10 mg kg(-1), i.p.) produced a marked hypotension and a reduction of the pressor responses elicited by phenylephrine (0.1, 0.3, and 3 microg kg(-1), i.v.). Pretreatment of the rats with either genistein (10 mg kg(-1) i.p., 2 h before endotoxin injection), L-NAME (0.1 mg kg(-1), i.p., 30 min before endotoxin injection), or a combination of both attenuated the hypotension caused by endotoxin. SNS in the rat isolated perfused mesenteric bed caused a frequency-dependent vasoconstrictor response, which was abolished by tetrodotoxin (10(-7) M), prazoscin (10(-7) M), and guanethidine (10(-7)M). In mesenteric vascular beds removed from rats injected with endotoxin, the vasoconstrictor responses to SNS were markedly impaired. Although genistein and L-NAME pretreatment attenuated the vascular hyporeactivity to phenylephrine, they did not improve the impaired SNS response of the isolated vascular bed of endotoxin-treated animals. These results indicate that genistein and L-NAME pretreatment prevent the hypotension and the delayed hyporeactivity to phenylephrine induced by endotoxin, but they failed to restore the vascular hyporeactivity to SNS.
ISSN:	1073-2322 1540-0514
DOI:	10.1097/00024382-200211000-00011